NEW YORK (TheStreet) -- CHANGE IN RATINGS
Accenture (ACN) was upgraded to Outperform at Wells Fargo. Visibility is improving, and business fundamentals appear to have reached an inflection point.
Archer-Daniels Midland (ADM) was downgraded to Market Perform at BMO Capital. Valuation call, based on a $36 price target.
Beacon Roofing (BECN) was downgraded from Outperform to Neutral at Robert Baird. $16 price target. Shingle pricing has turned negative.ConocoPhillips (COP) was downgraded to Underweight at Morgan Stanley. Valuation call, based on a $56 price target. Deere (DE) was downgraded to Market Perform at Wells Fargo. Company is not likely to raise guidance above current consensus expectations. Amdocs (DOX) was started with a Hold rating at ThinkEquity. $30 price target. Future growth will most likely be driven by acquisitions. Idacorp (IDA) was upgraded from Hold to Buy at Keybanc. $38.50 price target. Two tax deductions will benefit equity value. Limited Brands (LTD) was downgraded to Sell at Goldman Sachs. $24 price target. Company faces earnings headwinds in 2011. Norfolk Southern (NSC) was downgraded to Market Perform at Wells Fargo. Valuation call, as coal demand could wane. Rubicon Technology (RBCN) was initiated with a Sell rating at Merriman, Curhan Ford. Supply has caught up to demand in LCD lighting. The Hanover Insurance Group (THG) was downgraded to Equal Weight from Overweight at Barclays. Less earnings power and reduced ROE improvement, Barclays said. Price target cut to $46 from $49. Walgreen (WAG) was upgraded from Equal-Weight to Overweight at Morgan Stanley. $40 price target. Company faces easy comparisons for the flu season. Wright Medical (WMGI) was downgraded from Outperform to Neutral at Robert Baird. $17 price target. Company could struggle to achieve consensus earnings expectations. Xilinx (XLNX) was downgraded from Neutral to Sell at Goldman Sachs. Estimates were also cut, as cyclical pressures could hurt earnings. $22 price target.
STOCK COMMENTS / EPS CHANGESAccenture 2011 and 2012 estimates boosted to $3.03 and $3.46, respectively, at Credit Suisse. Banking on enterprise spend recovery, Credit Suisse said. Maintain Outperform rating and $55 price target. Accenture estimates, target increased at Citigroup. Estimates were raised through 2012. Company had a good quarter and boosted guidance. Buy rating and new $53 price target. Altera (ALTR) estimates, target reduced at Goldman. Estimates were cut through 2012, Goldman Sachs said. Company faces cyclical headwinds. Neutral rating and new $26 price target. Covance (CVD) estimates, target boosted at Jefferies. Shares now seen reaching $54, according to Jefferies. Estimates also upped, given the new $2.2 billion contract from SNY. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV